Journey Medical Corporation (NASDAQ:DERM) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's 2024 Financial Results and Corporate Update Conference Call.
Journey Medical Corp (DERM)
Market is closed
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.04 | 10,000 | Director | 144,245 | 2024-03-25 | Filing | |
| $3.48 | 10,000 | Officer, Director | 2,163,430 | 2024-03-22 | Filing | |
| $3.47 | 30,000 | Director | 134,717 | 2024-03-22 | Filing | |
| $3.40 | 20,000 | Director | 134,245 | 2024-03-22 | Filing | |
| $2.98 | 33,000 | Director | 104,717 | 2023-10-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.01 | 49,271 | Officer, Director | 2,003,147 | 2025-03-11 | Filing | |
| $5.01 | 14,905 | Officer, Director | 2,052,418 | 2025-03-07 | Filing | |
| $5.04 | 25,551 | Officer, Director | 2,067,323 | 2025-03-06 | Filing | |
| $5.13 | 18,147 | Officer, Director | 2,092,874 | 2025-03-05 | Filing | |
| $5.04 | 28,901 | Officer, Director | 2,111,021 | 2025-03-04 | Filing |
News See All
Journey Medical Corporation (DERM): A Bull Case Theory
We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will summarize the bulls’ thesis on DERM.
Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)
Minot Light Capital, an investment management firm, recently released its fourth-quarter 2024 investor letter. A copy of the same can be downloaded here.
Journey Medical Corporation (NASDAQ:DERM) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good day, and welcome to Journey Medical's Second Quarter 2024 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (NASDAQ:DERM) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's First Quarter 2024 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (NASDAQ:DERM) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon. And welcome to Journey Medical’s Third Quarter 2023 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (NASDAQ:DERM) Q2 2023 Earnings Call Transcript
Operator: Ladies and Gentleman, thank you for standing by. Good afternoon and welcome to Journey Medical Second Quarter 2023 Financial Results and Corporate Update conference call.
Journey Medical Corporation (NASDAQ:DERM) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Journey Medical's First Quarter 2023 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (NASDAQ:DERM) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
Here's What Hedge Funds Think About Dermira Inc (DERM)
Is Dermira Inc (NASDAQ:DERM) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.
Billionaire Hedge Funds
